Zusammenfassung
In Deutschland werden aktuell ca. 80.000 Patienten mit einem Dialyseverfahren behandelt. Im Rahmen der ambulanten kassenärztlichen Qualitätskontrolle ergibt sich für die Hämodialyse (HD) ein Anteil von 95 %, 5 % der Patienten werden mit der Peritonealdialyse (PD) behandelt (MNC: Jahresbericht Dialyse 2011 für den Gemeinsamen Bundesausschuss). Das durchschnittliche Alter der Dialysepatienten hat sich in den letzten Jahren kontinuierlich erhöht. 2011 betrug es im Median 70 Jahre. 1731 der 4933 Patienten, die in 2011 neu mit der Dialyse begannen, waren älter als 75 Jahre.
Similar content being viewed by others
Literatur
Bargman JM, Thorpe KE, Churchill DN (2001) Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12:2158–2162
Brent J (2009) Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med 360:2216–2223
Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS (2010) In-center hemodialysis six times per week versus three times per week. N Engl J Med 363:2287–2300
Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619
Derksen RH, Schuurman HJ, Meyling FH, Struyvenberg A, Kater L (1984) The efficacy of plasma exchange in the removal of plasma components. J Lab Clin Med 104:346–354
Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019
Herget-Rosenthal S, Quellmann T, Linden C, Hollenbeck M, Jankowski V, Kribben A (2010) How does late nephrological co-management impact chronic kidney disease? - an observational study. Int J Clin Pract 64:1784–1792
Higgins RM, Hearing S, Goldsmith DJ, Keevil B, Venning MC, Ackrill P (1995) Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis? Postgrad Med J 71:224–226
Hollenbeck M, Kutkuhn B, Aul C, Leschke M, Willers R, Grabensee B (1998) Haemolytic-uraemic syndrome and thrombotic-thrombocytopenic purpura in adults: clinical findings and prognostic factors for death and end-stage renal disease. Nephrol Dial Transplant 13:76–81
Hollenbeck M, Mickley V, Brunkwall J, Daum H, Haage P, Ranft J, Schindler R, Thon P, Vorwerk D (2009) Interdisziplinäre Empfehlung deutscher Fachgesellschaften zum Gefäßzugang zur Hämodialyse. Der Nephrologe 4:158–176
Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180–2188
Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35:904–914
Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL (2008) Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int 73:1282–1288
Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A (2013) High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 24:487–497
McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
Riegel W, Hahn K, Kreutz R, Weber M, Zidek W, Schmieder R (2005) BENEFIT Kidney-significance of a nephrology screening at intervention outset and therapy success. Dtsch Med Wochenschr 130:792–796
Riegel W, Kruger B, Schnulle P (2012) Dialysis and renal transplantation. Update 2012. Dtsch Med Wochenschr 137:2567–2570
Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325:393–397
Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK (2006) Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69:1222–1228
Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH (2010) Guidelines on the use of therapeutic apheresis in clinical practice–evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25:83–177
Tattersall J, Dekker F, Heimburger O, Jager KJ, Lameire N, Lindley E, Van BW, Vanholder R, Zoccali C (2011) When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study. Nephrol Dial Transplant 26:2082–2086
Winters JL, Gloor JM, Pineda AA, Stegall MD, Moore SB (2004) Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apher 19:79–85
Wu IW, Wang SY, Hsu KH, Lee CC, Sun CY, Tsai CJ, Wu MS (2009) Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality–a controlled cohort study based on the NKF/DOQI guidelines. Nephrol Dial Transplant 24:3426–3433
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Hollenbeck, M., Gross, T., Girndt, M. (2014). Dialysetherapie und Plasmapherese. In: Lehnert, H. (eds) SpringerReference Innere Medizin. SpringerReference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54676-1_86-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-54676-1_86-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-54676-1
eBook Packages: Springer Referenz Medizin